首页> 外文期刊>European journal of human genetics: EJHG >Heterozygous deletions at the ZEB1 locus verify haploinsufficiency as the mechanism of disease for posterior polymorphous corneal dystrophy type 3
【24h】

Heterozygous deletions at the ZEB1 locus verify haploinsufficiency as the mechanism of disease for posterior polymorphous corneal dystrophy type 3

机译:ZEB1基因座处的杂合缺失证实单倍体功能不足是3型多态性角膜营养不良的疾病机制

获取原文
获取原文并翻译 | 示例
           

摘要

A substantial proportion of patients with posterior polymorphous corneal dystrophy (PPCD) lack a molecular diagnosis. We evaluated 14 unrelated probands who had a clinical diagnosis of PPCD who were previously determined to be negative for mutations in ZEB1 by direct sequencing. A combination of techniques was used including whole-exome sequencing (WES), single-nucleotide polymorphism (SNP) array copy number variation (CNV) analysis, quantitative real-time PCR, and long-range PCR. Segregation of potentially pathogenic changes with disease was confirmed, where possible, in family members. A putative run of homozygosity on chromosome 10 was identified by WES in a three-generation PPCD family, suggestive of a heterozygous deletion. SNP array genotyping followed by long-range PCR and direct sequencing to define the breakpoints confirmed the presence of a large deletion that encompassed multiple genes, including ZEB1. Identification of a heterozygous deletion spanning ZEB1 prompted us to further investigate potential CNVs at this locus in the remaining probands, leading to detection of two additional heterozygous ZEB1 gene deletions. This study demonstrates that ZEB1 mutations account for a larger proportion of PPCD than previously estimated, and supports the hypothesis that haploinsufficiency of ZEB1 is the underlying molecular mechanism of disease for PPCD3.
机译:后部多形性角膜营养不良(PPCD)的患者中,很大一部分缺乏分子诊断。我们评估了14位临床诊断为PPCD的不相关先证者,这些先证者先前通过直接测序确定为ZEB1突变阴性。使用了多种技术的组合,包括全外显子测序(WES),单核苷酸多态性(SNP)阵列拷贝数变异(CNV)分析,实时定量PCR和长距离PCR。在可能的情况下,确认了家人中潜在致病性变化与疾病的隔离。 WES在三代PPCD家族中鉴定了10号染色体上纯合子的推定运行,提示杂合缺失。 SNP阵列基因分型,然后进行长距离PCR和直接测序以定义断点,证实存在包含多个基因(包括ZEB1)的大缺失。跨越ZEB1杂合缺失的鉴定促使我们进一步研究该基因在其余先证者中的潜在CNV,从而导致检测到另外两个杂合ZEB1基因缺失。这项研究表明,ZEB1突变占PPCD的比例比以前估计的更大,并支持ZEB1的单倍剂量不足是PPCD3疾病的潜在分子机制的假说。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号